Drug Discovery
Drug discovery, the process of identifying and developing new therapeutic agents, is being revolutionized by artificial intelligence. Current research focuses on improving the accuracy and efficiency of computational models for predicting molecular properties, drug-target interactions, and pharmacokinetics, employing techniques like graph neural networks, transformers, and diffusion models, often enhanced by self-supervised learning and multi-task learning strategies. These advancements aim to accelerate the lengthy and expensive drug development pipeline, ultimately leading to faster identification of effective and safer drugs. The integration of large language models and quantum computing further expands the possibilities for innovative drug design and discovery.
Papers
ACEGEN: Reinforcement learning of generative chemical agents for drug discovery
Albert Bou, Morgan Thomas, Sebastian Dittert, Carles Navarro Ramírez, Maciej Majewski, Ye Wang, Shivam Patel, Gary Tresadern, Mazen Ahmad, Vincent Moens, Woody Sherman, Simone Sciabola, Gianni De Fabritiis
Collaborative Intelligence in Sequential Experiments: A Human-in-the-Loop Framework for Drug Discovery
Jinghai He, Cheng Hua, Yingfei Wang, Zeyu Zheng
Improving Molecule Generation and Drug Discovery with a Knowledge-enhanced Generative Model
Aditya Malusare, Vaneet Aggarwal
A Survey of Generative AI for de novo Drug Design: New Frontiers in Molecule and Protein Generation
Xiangru Tang, Howard Dai, Elizabeth Knight, Fang Wu, Yunyang Li, Tianxiao Li, Mark Gerstein